Predictors of liver transplant eligibility for patients with hepatocellular carcinoma in a safety net hospital

Digestive Diseases and Sciences

Volumn 57, Issue 2, 2012, Pages 580-586

  Singal, Amit G ^a,b,c,d   Chan, Vincent ^a,b   Getachew, Yonas ^a,b   Guerrero, Richard ^a,b   Reisch, Joan S ^c   Cuthbert, Jennifer A ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b PARKLAND HEALTH AND HOSPITAL SYSTEM   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Hepatocellular carcinoma; Liver transplantation; Presentation; Safety net hospital; Tumor stage

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; CLINICAL FEATURE; FEMALE; HOSPITAL PLANNING; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIPLE CANCER; PORTAL VEIN THROMBOSIS; PREDICTOR VARIABLE; PRIORITY JOURNAL; RACE DIFFERENCE; SEX RATIO; URBAN AREA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CHI-SQUARE DISTRIBUTION; FEMALE; HOSPITALS, COUNTY; HOSPITALS, URBAN; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PATIENT SELECTION; PROGNOSIS; RETROSPECTIVE STUDIES; TEXAS;

EID: 84856718557     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-011-1904-7     Document Type: Article

References (23)

1. SF Altekruse KA McGlynn ME Reichman 2009 Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005 J Clin Oncol 27 1485 1491 19224838 10.1200/JCO.2008.20.7753
2. HB El-Serag KL Rudolph 2007 Hepatocellular carcinoma: epidemiology and molecular carcinogenesis Gastroenterology 132 2557 2576 17570226 10.1053/j.gastro.2007.04.061 1:CAS:528:DC%2BD2sXnvFOgsrw%3D (Pubitemid 46890874)
3. AG Singal ML Volk A Waljee, et al. 2009 Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis Aliment Pharmacol Ther 30 37 47 19392863 10.1111/j.1365-2036.2009.04014.x 1:STN:280:DC%2BD1MvltlyqtQ%3D%3D
4. JM Llovet J Bruix 2000 Early diagnosis and treatment of hepatocellular carcinoma Baillieres Best Pract Res Clin Gastroenterol 14 991 1008 11139351 10.1053/bega.2000.0143 1:STN:280:DC%2BD3M7isF2itg%3D%3D (Pubitemid 32094270)
5. GN Ioannou JD Perkins RL Carithers Jr 2008 Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival Gastroenterology 134 1342 1351 18471511 10.1053/j.gastro.2008.02.013 (Pubitemid 351615357)
6. JM Llovet J Bustamante A Castells, et al. 1999 Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials Hepatology 29 62 67 9862851 10.1002/hep.510290145 1:STN:280:DyaK1M%2FotFKrsw%3D%3D (Pubitemid 29023987)
7. Regenstein M, Huang J. Stresses to the safety net: the public hospital perspective. In: Kaiser Commission on Medicaid and the Uninsured. Washington DC: Kaiser Family Foundation; 2005.
8. ZM Younossi M Stepanova 2010 Hepatitis C virus infection, age, and Hispanic ethnicity increase mortality from liver cancer in the United States Clin Gastroenterol Hepatol 8 718 723 20435163 10.1016/j.cgh.2010.04.017
9. A Artinyan B Mailey N Sachez-Leuge, et al. 2010 Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United States Cancer 116 1367 1377 20101732 10.1002/cncr.24817
10. RJ Wong DA Corley 2009 Survival differences by race/ethnicity and treatment for localized hepatocellular carcinoma within the United States Dig Dis Sci 54 2031 2039 19117131 10.1007/s10620-008-0661-8
11. AE Hendifar D Yang S Iqbal H Lenz A El-Khoueiry 2009 Gender disparities in hepatocellular cancer survival J Clin Oncol 27 e15517
12. J Bruix M Sherman 2005 Management of hepatocellular carcinoma Hepatology 42 1208 1236 16250051 10.1002/hep.20933 (Pubitemid 43112690)
13. N Onaca GL Davis LW Jennings, et al. 2009 Improved results of transplantation for hepatocellular carcinoma: a report from the International Registry of Hepatic Tumors in Liver Transplantation Liver Transpl 15 574 580 19479800 10.1002/lt.21738
14. N Kemmer G Neff M Secic, et al. 2008 Ethnic differences in hepatocellular carcinoma: implications for liver transplantation Dig Dis Sci 53 551 555 17562173 10.1007/s10620-007-9872-7 (Pubitemid 351170014)
15. LL Wong N Tasi W Limm, et al. 2004 Liver transplant for hepatocellular cancer: a treatment for the select few Clin Transplant 18 205 210 15016137 10.1046/j.1399-0012.2003.00157.x (Pubitemid 38404653)
16. M Haque A Zariat 2008 Disparities in liver transplantation for localized hepatocellular carcinoma: race or socioeconomic class? Am J Gastroenterol 103 1839 1840 18691200 10.1111/j.1572-0241.2008.01959-7.x author reply 1840
17. DA Axelrod EA Pomfret 2008 Race and sex disparities in liver transplantation: progress toward achieving equal access? JAMA 300 2425 2426 19033595 10.1001/jama.2008.732 1:CAS:528:DC%2BD1cXhsVCjsrvI
18. K Dohmen H Sigematsu K Irie, et al. 2003 Longer survival in female than male with hepatocellular carcinoma J Gastroenterol Hepatol 18 267 272 12603526 10.1046/j.1440-1746.2003.02936.x (Pubitemid 36513155)
19. CA Moylan CW Brady JL Johnson, et al. 2008 Disparities in liver transplantation before and after introduction of the MELD score JAMA 300 2371 2378 19033587 10.1001/jama.2008.720 1:CAS:528:DC%2BD1cXhsVCgtbrE
20. MJ Englesbe DE Schaubel S Cai, et al. 2010 Portal vein thrombosis and liver transplant survival benefit Liver Transpl 16 999 1005 20677291 10.1002/lt.22105
21. K Han GV Tzimas JS Barkun, et al. 2007 Preoperative alpha-fetoprotein slope is predictive of hepatocellular carcinoma recurrence after liver transplantation Can J Gastroenterol 21 39 45 17225881 (Pubitemid 46277174)
22. SY Peng WJ Chen PL Lai, et al. 2004 High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations Int J Cancer 112 44 50 15305374 10.1002/ijc.20279 1:CAS:528:DC%2BD2cXnvVWlsLo%3D (Pubitemid 39249490)
23. JD Browning LS Szczepaniak R Dobbins, et al. 2004 Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity Hepatology 40 1387 1395 15565570 10.1002/hep.20466 (Pubitemid 39657013)